Cerebroprotective Effect of Melatonin in Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT05857046

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05857046
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Mexico (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05857046. Randomized; single masking; primary purpose treatment. Start 2024-03-01 (actual); primary completion 2025-03-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cerebroprotective Effect of Melatonin in Stroke
Condition
Stroke, Acute Ischemic
Condition
Strokes Thrombotic
Intervention (Drug)
Melatonin 10 MG
Intervention (Other)
Placebo
Lead sponsor
Coordinación de Investigación en Salud, Mexico (class: other government)
Collaborator
Instituto Mexicano del Seguro Social (class: other government)
Collaborator
Universidad Michoacana de San Nicolás de Hidalgo (class: not stated)
Collaborator
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (class: other government)

Record details

Record id
cardio:ct-nct05857046
Content hash
8221f95ea682b880fbb328b64b028c049f3d190c5a0a52e7a07107717f918766